journal article·2017-06Open access

Optimisation of the self-assembly process: production of stable, alginate-based polyelectrolyte nanocomplexes with protamine

Maria Dul, Krzysztof J. Paluch, Anne Marie Healy, Astrid Sasse, Lidia Tajber

Journal of Nanoparticle Research· Volume 19· Issue 6

Abstract

The aim of this work was to investigate the possibility of covalent cross-linker-free, polyelectrolyte complex formation at the nanoscale between alginic acid (as sodium alginate, ALG) and protamine (PROT). Optimisation of the self-assembly conditions was performed by varying the type of polymer used, pH of component solutions, mass mixing ratio of the components and the speed and order of component addition on the properties of complexes. Homogenous particles with nanometric sizes resulted when an aqueous dispersion of ALG was rapidly mixed with a solution of PROT. The polyelectrolyte complex between ALG and PROT was confirmed by infrared spectroscopy. To facilitate incorporation of drugs soluble at low pH, pH of ALG dispersion was decreased to 2; however, no nanoparticles (NPs) were formed upon complexation with PROT. Adjusting pH of PROT solution to 3 resulted in the formation of cationic or anionic NPs with a size range 70–300 nm. Colloidal stability of selected alginic acid low/PROT formulations was determined upon storage at room temperature and in liquid media at various pH. Physical stability of NPs correlated with the initial surface charge of particles and was time- and pH-dependent. Generally, better stability was observed for anionic NPs stored as native dispersions and in liquids covering a range of pH.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Advanced Drug Delivery Systems · Polymer Surface Interaction Studies · Hydrogels: synthesis, properties, applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (49)

Show source-provided references
1. Andriamanantoanina H, Rinaudo M (2010) Relationship between the molecular structure of alginates and their gelation in acidic conditions. Polym Int 59:1531–154110.1002/pi.2943 ↗
2. Augst AD, Kong HJ, Mooney DJ (2006) Alginate hydrogels as biomaterials. Macromol Biosc 6:623–63310.1002/mabi.200600069 ↗
3. Avadi MR, Sadeghi AMM, Dounighi NM, Dinarvand R, Atyabi F, Rafiee-Tehrani M (2011) Ex vivo evaluation of insulin nanoparticles using chitosan and arabic gum. ISRN Pharmaceutics. article ID 860109. doi: 10.5402/2011/86010910.5402/2011/860109 ↗
4. Awotwe-Otoo D, Agarabi C, Keire D, Lee S, Raw A, Yu L, Habib MJ, Khan MA, Shah RB (2012) Physicochemical characterization of complex drug substances: evaluation of structural similarities and differences of protamine sulfate from various sources. AAPS J 14:619–62610.1208/s12248-012-9375-0 ↗
5. Berger J, Reist M, Mayer JM, Felt O, Gurny R (2004) Structure and interactions in chitosan hydrogels formed by complexation or aggregation for biomedical applications. Eur J Pharm Biopharm 57:35–5210.1016/S0939-6411(03)00160-7 ↗
6. Bertoluzza A, Bonora S, Fini G, Morelli MA, Simoni R (1983) Phospholipid–protein molecular interactions in relation to immuno-logical processes. J Raman Spectrosc 14:395–40010.1002/jrs.1250140607 ↗
7. Birch NP, Schiffman JD (2014) Characterization of self-assembled polyelectrolyte complex nanoparticles formed from chitosan and pectin. Langmuir 30:3441–344710.1021/la500491c ↗
8. Boddohi S, Killingsworth CE, Kipper MJ (2008) Polyelectrolyte multilayer assembly as a function of pH and ionic strength using the polysaccharides chitosan and heparin. Biomacromolecules 9:2021–202810.1021/bm8002573 ↗
9. Carneiro-da-Cunha MG, Cerqueira MA, Souza BWS, Teixeira JA, Vicente AA (2011) Influence of concentration, ionic strength and pH on zeta potential and mean hydrodynamic diameter of edible polysaccharide solutions envisaged for multinanolayered films production. Carbohydr Polym 85:522–52810.1016/j.carbpol.2011.03.001 ↗
10. Chen JH, Heitmann JA, Hubbe MA (2003) Dependency of polyelectrolyte complex stoichiometry on the order of addition. 1. Effect of salt concentration during streaming current titrations with strong poly-acid and polybase. Colloids Surf A Physicochem Eng Asp 223:215–23010.1016/S0927-7757(03)00222-X ↗
11. Cheow WS, Hadinoto K (2012) Self-assembled amorphous drug-polyelectrolyte nanoparticle complex with enhanced dissolution rate and saturation solubility. J Colloid Interface Sci 367:518–52610.1016/j.jcis.2011.10.011 ↗
12. Daemi H, Barikani M (2012) Synthesis and characterization of calcium alginate nanoparticles, sodium homopolymannuronate salt and its calcium nanoparticles. Scientia Iranica F 19:2023–202810.1016/j.scient.2012.10.005 ↗
13. Delie F, Blanco-Prieto M (2005) Polymeric particulates to improve oral bioavailability of peptide drugs. Molecules 10:65–8010.3390/10010065 ↗
14. Dragan ES, Mihai M, Schwarz S (2006) Polyelectrolyte complex dispersions with a high colloidal stability controlled by the polyion structure and titrant addition rate. Colloids Surf A Physicochem Eng Asp 290:213–22110.1016/j.colsurfa.2006.05.022 ↗
15. Dul M, Paluch KJ, Kelly H, Healy AM, Sasse A, Tajber L (2015) Self-assembled carrageenan/protamine polyelectrolyte nanoplexes-investigation of critical parameters governing their formation and characteristics. Carbohydr Polym 123:339–34910.1016/j.carbpol.2015.01.066 ↗
16. Elsabahy M, Wooley KL (2012) Design of polymeric nanoparticles for biomedical delivery applications. Chem Soc Rev 41(7):2545–256110.1039/c2cs15327k ↗
17. George M, Abraham TE (2006) Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan—a review. J Control Release 114:1–1410.1016/j.jconrel.2006.04.017 ↗
18. Guarino V, Caputo T, Altobelli R, Ambrosio L (2015) Degradation properties and metabolic activities of alginate and chitosan polyelectrolytes for drug delivery and tissue engineering applications. AIMS Mater Sci 2:497–50210.3934/matersci.2015.4.497 ↗
19. Holme HK, Lindmo K, Kristiansen A, Smidsrød O (2003) Thermal depolymerisation of alginate in the solid state. Carbohydr Polym 54:431–43810.1016/S0144-8617(03)00134-6 ↗
20. Holme HK, Davidsen L, Kristiansen A, Smidsrød O (2008) Kinetics and mechanisms of depolymerisation of alginate and chitosan in aqueous solution. Carbohydr Polym 73:656–66410.1016/j.carbpol.2008.01.007 ↗
21. Hu Y, Yang T, Hu X (2012) Novel polysaccharide-based nanoparticle carriers prepared by polyelectrolyte complexation for protein delivery. Polym Bull 68:1183–119910.1007/s00289-011-0683-9 ↗
22. Lankalapalli S, Kolapalli VRM (2009) Polyelectrolyte complexes: a review of their applicability in drug delivery technology. Indian J Pharm Sci 71(5):481–48710.4103/0250-474X.58165 ↗
23. Leal D, Matsuhiro B, Rossi M, Caruso F (2008) FT-IR spectra of alginic acid block fractions in three species of brown seaweeds. Carbohydr Res 343:308–31610.1016/j.carres.2007.10.016 ↗
24. Lee KQ, Mooney DJ (2012) Alginate: properties and biomedical applications. Prog Polym Sci 37:106–12610.1016/j.progpolymsci.2011.06.003 ↗
25. Le-Tien C, Milette M, Mateescu M-A, Lacroix M (2004) Modified alginate and chitosan for lactic acid bacteria immobilization. Biotechnol Appl Biochem 39:347–35410.1042/BA20030054 ↗
26. Li P, Dai Y-N, Wei Q (2008) Chitosan-alginate nanoparticles as a novel drug delivery system for nifedipine. Int J Biomed Sci 4:221–22810.59566/IJBS.2008.4221 ↗
27. Li C, Hein S, Wang K (2013) Chitosan-carrageenan polyelectrolyte complex for the delivery of protein drugs. ISRN Biomaterials. article ID 629807. doi: 10.5402/2013/62980710.5402/2013/629807 ↗
28. Liechty WB, Kryscio DR, Slaughter BV, Peppas NA (2010) Polymers for drug delivery systems. Annu Rev Chem Biomol Eng 1:149–17310.1146/annurev-chembioeng-073009-100847 ↗
29. Mackay ME, Tuteja A, Duxbury PM, Hawker CJ, van Horn B, Guan Z, Chen G, Krishnan RS (2006) General strategies for nanoparticle dispersion. Science 311:1740–174310.1126/science.1122225 ↗
30. Mustafaev MI (1996) Polyelectrolyes in immunology. Turk J Chem 20:126–138
31. Ngwuluka NC, Ochekpe NA, Aruoma OI (2014) Naturapolyceutics: the science of utilizing natural polymers for drug delivery. Polymers 6:1312–133210.3390/polym6051312 ↗
32. Polexe RC, Delair T (2013) Elaboration of stable and antibody functionalized positively charged colloids by polyelectrolyte complexation between chitosan and hyaluronic acid. Molecules 18:8563–857810.3390/molecules18078563 ↗
33. Reynolds F, Weissleder R, Josephson L (2005) Protamine as an efficient membrane-translocating peptide. Bioconjug Chem 16:1240–124510.1021/bc0501451 ↗
34. Saether HV, Holme HK, Maurstad G, Smidsrod O, Stokke BT (2008) Polyelectrolyte complex formation using alginate and chitosan. Carbohydr Polym 74:813–82110.1016/j.carbpol.2008.04.048 ↗
35. Sankalia MG, Mashru RC, Sankalia JM, Sutariya VB (2007) Reversed chitosan–alginate polyelectrolyte complex for stability improvement of alpha-amylase: optimisation and physicochemical characterisation. Eur J Pharm Biopharm 65:215–23210.1016/j.ejpb.2006.07.014 ↗
36. Sarmento B, Ferreira D, Veiga F, Ribeiro A (2006) Characterisation of insulin-loaded alginate nanoparticles produced by ionotropic pre-gelation through DSC and FTIR studies. Carbohydr Polym 66:1–710.1016/j.carbpol.2006.02.008 ↗
37. Sarmento B, Bibeiro A, Veiga F, Ferreira D, Neufeld R (2007) Oral bioavailability of insulin contained in polysaccharide nanoparticles. Biomacromolecules 8:3054–306010.1021/bm0703923 ↗
38. Silva CM, Ribeiro AJ, Ferreira D, Veiga F (2006) Insulin encapsulation in reinforced alginate microspheres prepared by internal gelation. Eur J Pharm Sci 29:148–15910.1016/j.ejps.2006.06.008 ↗
39. Sinha VR, Kumria R (2001) Polysaccharides in colon-specific drug delivery. Int J Pharm 224:19–3810.1016/S0378-5173(01)00720-7 ↗
40. Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE (2001) Biodegradable polymeric nanoparticles as delivery devices. J Control Release 70:1–2010.1016/S0168-3659(00)00339-4 ↗
41. Srivastava A, Yadav T, Sharma S, Nayak A, Kumari A, Mishra N (2016) Polymers in drug delivery. J Biosci Med 4:69–84
42. Temsamani J, Vidal P (2004) The use of cell-penetrating peptides for drug delivery. Drug Discov Ther 9:1012–101910.1016/S1359-6446(04)03279-9 ↗
43. Tønnesen HH, Karlsen J (2002) Alginate in drug delivery systems. Drug Dev Ind Pharm 28:621–63010.1081/DDC-120003853 ↗
44. Umerska A, Paluch KJ, Inkielewicz-Stepniak I, Santoz-Martinez MJ, Corrigan OI, Medina C, Tajber L (2012) Exploring the assembly process and properties of novel cross-linker free hyaluronate-based polyelectrolyte complex nanocarriers. Int J Pharm 436:75–8710.1016/j.ijpharm.2012.07.011 ↗
45. Umerska A, Paluch KJ, Santos-Martinez MJ, Corrigan OI, Medina C, Tajber L (2014) Self-assembled hyaluronate/protamine polyelectrolyte nanoplexes: synthesis, stability, biocompatibility and potential use as peptide carriers. J Biomed Nanotechnol 10:3658–367310.1166/jbn.2014.1878 ↗
46. Umerska A, Paluch KJ, Santos-Martinez MJ, Corrigan OI, Medina C, Tajber L (2015) Chondroitin-based nanoplexes as peptide delivery systems—investigations into the self-assembly process, solid-state and extended release characteristics. Eur J Pharm Biopharm 93:242–25310.1016/j.ejpb.2015.04.006 ↗
47. Wee S, Gombotz WR (1998) Protein release from alginate matrices. Adv Drug Del Rev 31:267–28510.1016/S0169-409X(97)00124-5 ↗
48. Wernig K, Griesbacher M, Andreae F, Hajos F, Wagner J, Mosgoeller W, Zimmer A (2008) Depot formulation of vasoactive intestinal peptide by protamine-based biodegradable nanoparticles. J Control Release 130(2):192–19810.1016/j.jconrel.2008.06.005 ↗
49. Yu X, Hou J, Shi Y, Su C, Zhao L (2016) Preparation and characterization of novel chitosan-protamine nanoparticles for nucleus-targeted anticancer drug delivery. Int J Nanomedicine 11:6035–604610.2147/IJN.S117066 ↗